Zymo Research, also known as "The Epigenetics Company", has been serving the academic and biopharmaceutical scientific communities by providing DNA and RNA purification products since its inception in 1994.
It was an early adopter in the epigenetics field and offers a line of products used in DNA methylation detection and quantitation. In addition to the epigenetic and nucleic acid purification products, Zymo also provides the first commercially available microbiomics standards for the development, evaluation, calibration, and validation of complex microbiomics workflows encompassing sample collection, sample preparation, and analyses. It is also the first supplier to validate every step of the process using Microbial Community Standards to ensure our tools and services are accurate. The ZymoBIOMICS™ portfolio has been developed as a comprehensive solution for microbiomics and metagenomics from collection to analyses.